It should be noted that while most of the AML cell lines treated with LNS8801 upregulated cleaved caspase-8, there was only a modest increase in cleaved caspase-8 and a more notable increase in cleaved caspase-9 in the (relatively) LNS8801-resistant line THP1. The gene discussed is CASP9; the disease is acute myeloid leukemia.